Lv61
1710 积分 2023-03-24 加入
Human Metapneumovirus–, Respiratory Syncytial Virus–, and Influenza-Associated Pneumonia Hospitalizations in Colorado Adults Aged ≥50 Years, 2016–2023
5天前
已完结
Impact of nirsevimab immunoprophylaxis on respiratory syncytial virus-related outcomes in hospital and primary care after two consecutive seasons: a population-based retrospective cohort study in infants in their second year of life in Catalonia, Spain
11天前
已完结
Effectiveness and Impact of Maternal RSV Immunization and Nirsevimab on Medically Attended RSV in US Children
11天前
已关闭
Respiratory Syncytial Virus Disease Burden and Nirsevimab Effectiveness in Young Children From 2023-2024
11天前
已完结
Real-world effectiveness of nirsevimab immunisation against bronchiolitis in infants: a case–control study in Paris, France
12天前
已完结
A population-based cohort of drug exposures and adverse pregnancy outcomes in China (DEEP): rationale, design, and baseline characteristics
15天前
已完结
Respiratory Syncytial Virus After CAR T-cell Therapy: Risk Factors and Outcomes in a Multicenter Retrospective Cohort
16天前
已完结
Secondary Pneumococcal Disease in Veterans With Viral Respiratory Infections
16天前
已完结
Risk of Cardiorespiratory Events Increases After Severe RSV Infection
16天前
已关闭
Risk of Primary Infection and Reinfection With Respiratory Syncytial Virus
1个月前
已完结
皖公网安备34019202002308
